Ophthalmic Risks and Complications Associated with the Treatment of Systemic Vasculitis

Steven Yeh, James T. Rosenbaum

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

A number of medications used to treat autoimmune systemic vasculitis may lead to ophthalmic complications. Long-term corticosteroid use may lead to cataract, glaucoma or, rarely, central serous chorioretinopathy. Corticosteroid-sparing immunosuppressive medications, particularly cyclophosphamide and/or the biologic agents, may lead to opportunistic eye infections including CMV retinitis, progressive outer retinal necrosis and fungal chorioretinitis due to fungemia. Other medications such as hydroxychloroquine and chloroquine may result in a distinct maculopathy, which may lead to central and paracentral visual loss and loss of color vision. Other medications including rifabutin, which causes uveitis, and bisphosphonates, which may lead to uveitis and scleritis, are also discussed in this chapter.

Original languageEnglish (US)
Title of host publicationInflammatory Diseases of Blood Vessels
Subtitle of host publicationSecond Edition
PublisherWiley-Blackwell
Pages495-504
Number of pages10
ISBN (Print)9781444338225
DOIs
StatePublished - May 3 2012

Keywords

  • Bisphosphonate
  • Cataract
  • Corticosteroid-associated glaucoma
  • Cytomegalovirus retinitis
  • Hydroxychloroquine
  • Ocular vasculitis
  • Opportunistic infection
  • Progressive outer retinal necrosis
  • Systemic vasculitis

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Ophthalmic Risks and Complications Associated with the Treatment of Systemic Vasculitis'. Together they form a unique fingerprint.

  • Cite this

    Yeh, S., & Rosenbaum, J. T. (2012). Ophthalmic Risks and Complications Associated with the Treatment of Systemic Vasculitis. In Inflammatory Diseases of Blood Vessels: Second Edition (pp. 495-504). Wiley-Blackwell. https://doi.org/10.1002/9781118355244.ch45